Inventor
TAVARES FRANCIS XAVIER
US25 patents
⚠️ This page may combine multiple inventors who share the name “TAVARES FRANCIS XAVIER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
G1 THERAPEUTICS INC
18 patentsUS9527857B2Dec 27, 2016
HSPC-sparing treatments for RB-positive abnormal cellular proliferation
G1 THERAPEUTICS INC31 citations98
US9487530B2Nov 8, 2016
Transient protection of normal cells during chemotherapy
G1 THERAPEUTICS INC36 citations98
US9464092B2Oct 11, 2016
Transient protection of normal cells during chemotherapy
G1 THERAPEUTICS INC29 citations98
US9260442B2Feb 16, 2016
Lactam kinase inhibitors
G1 THERAPEUTICS INC42 citations98
US10434104B2Oct 8, 2019
HSPC-sparing treatments for Rb-positive abnormal cellular proliferation
G1 THERAPEUTICS INC7 citations92
US10085992B2Oct 2, 2018
Transient protection of normal cells during chemotherapy
G1 THERAPEUTICS INC16 citations92
US10076523B2Sep 18, 2018
HSPC-sparing treatments for RB-positive abnormal cellular proliferation
G1 THERAPEUTICS INC15 citations92
US9931345B2Apr 3, 2018
Transient protection of normal cells during chemotherapy
G1 THERAPEUTICS INC14 citations92
US9745316B2Aug 29, 2017
Lactam kinase inhibitors
G1 THERAPEUTICS INC14 citations92
US11717523B2Aug 8, 2023
Transient protection of normal cells during chemotherapy
G1 THERAPEUTICS INC3 citations84
US11040042B2Jun 22, 2021
Transient protection of normal cells during chemotherapy
G1 THERAPEUTICS INC5 citations84
US10966984B2Apr 6, 2021
Transient protection of normal cells during chemotherapy
G1 THERAPEUTICS INC5 citations84
US10925878B2Feb 23, 2021
HSPC-sparing treatments for RB-positive abnormal cellular proliferation
G1 THERAPEUTICS INC5 citations84
US10709711B2Jul 14, 2020
Highly active anti-neoplastic and anti-proliferative agents
G1 THERAPEUTICS INC6 citations84
US10464940B2Nov 5, 2019
Lactam kinase inhibitors
G1 THERAPEUTICS INC5 citations84
US9856268B2Jan 2, 2018
Lactam kinase inhibitors
G1 THERAPEUTICS INC9 citations84
US10865210B2Dec 15, 2020
Synthesis of n-(heteroaryl)-pyrrolo[3,2-d]pyrimidin-2-amines
G1 THERAPEUTICS INC9 citations81
US11629150B2Apr 18, 2023
Synthesis of N-(heteroaryl)-pyrrolo[3,2-d]pyrimidin-2-amines
G1 THERAPEUTICS INC3 citations70
SMITHKLINE BEECHAM CORP
3 patentsUS7582630B2Sep 1, 2009
Pyradazine compounds as GSK-3 inhibitors
SMITHKLINE BEECHAM CORP7 citations61
US7279473B2Oct 9, 2007
Pyrazolopyridazine derivatives
SMITHKLINE BEECHAM CORP5 citations58
US7282512B2Oct 16, 2007
Cycloalkyl ketoamides derivatives useful as cathepsin K inhibitors
SMITHKLINE BEECHAM CORP1 citations47